SC bench says panel to reassess reservation criteria was 'probably set up to justify' the criteria. It is likely to pronounce its verdict on petitions challenging EWS quota Friday.
Advice comes at a time when India accounts for a 5th of global generic drug supply & 40% of generics used in US. However, this strength in finished formulations relies on imported ingredients.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS